Clay Siegall is this incredibly interesting CEO in the biotechnology world. You can head on over to his blog on WordPress.com to see some of the disparate thoughts that the man has. The CEO of Seattle Genetics is a big-time NFL football fan and much of his blog reflects that. Most of his new seems to be centered around the Los Angeles Rams. The NFL off-season is in full swing and Clay Siegall seems to be very interested in player movements.
But that is not all that the interesting CEO has to offer on his blog. He seems to be very interested in the new Republican administration’s repeal of Obama care. One of his blog features advice and news and how couples can deal with the repeal and replace of the health care act. Clay Siegall seems to think that the repeal and replace of the law is going rather awkwardly and his advice on the blog reflects that. It is pretty cool to see a CEO of a biotechnology company that is involved with healthcare freely giving out advice on how to navigate the healthcare world.
Clay Siegall cofounded his genetics business back in 1998. He was originally a scientist that was laser focused on cancer and the many treatments that may be innovated through genetic technologies. His company is rigorously committed to scientific principles and Clay Siegall continually shows that through unabashed research and drug development. Despite the obstacles, he is committed to helping patients with cancer.
Clay Siegall has guided Seattle Genetics to a global market where the company’s drugs are approved in more than 65 countries. The government has been issuing proprietary patents and licenses to Seattle Genetics for cancer research with much help from Clay Siegall. The company also seems to be soaring financially. Through different capital raising efforts, Clay Siegall has managed to pull in over $1.2 billion in public and private financing since the company originally went public back in 2001.
According to BioPharmaDive.com, Clay Siegall powerful medications to help cancer patients. They have quoted the CEO saying that his company is studying all moving parts and pieces.